People
Mark Sentenac is a partner with King & Spalding’s Trial and Global Disputes. Mark’s practice focuses on representing pharmaceutical and medical device manufacturers in complex products liability litigation throughout the country, including in federal multidistrict litigation and state coordinated proceedings. He has experience in all phases of litigation, including trials, taking depositions, working with subject matter experts in complex scientific fields, coordinating large-scale electronic discovery and drafting dispositive, pre-trial and appellate briefs. In his practice, Mark has assisted in advising companies in all aspects of product safety, including on risk assessments, government investigations, product recalls and indemnity issues.
Publications
Recognition
J.D., University of San Francisco School of Law, magna cum laude
B.S., University of California-Santa Barbara
California
Georgia
U.S. District Court for the Eastern District of California
U.S. District Court for the Northern District of California
U.S. District Court for the Southern District of California
July 15, 2022
Mark Sentenac, Susan Clare and Ryan Kearney advise AbbVie and Allergan in a product liability dispute
December 3, 2021
K&S elects 32 new partners and promotes 16 counsel across 16 cities
Member of team serving as national coordinating and trial counsel in nationwide product liability litigation involving a leading pharmaceutical company’s antidepressant medication. Mark’s experience includes trial preparation and briefing dispositive and pre-trial motions.
Acted as national coordinating counsel for a multinational medical device manufacturer in claims related to its orthopedic products, including representing the manufacturer before the U.S. Judicial Panel on Multidistrict Litigation.
Member of team advising multinational pharmaceutical company on recall of popular consumer health product.
See more
February 3, 2022
Upcoming Rulings Key To Defining PREP Act Protections
January 11, 2017
Will The Learned Intermediary Doctrine Survive A New Paradigm?
July 15, 2022
Mark Sentenac, Susan Clare and Ryan Kearney advise AbbVie and Allergan in a product liability dispute
December 3, 2021
K&S elects 32 new partners and promotes 16 counsel across 16 cities
Member of team serving as national coordinating and trial counsel in nationwide product liability litigation involving a leading pharmaceutical company’s antidepressant medication. Mark’s experience includes trial preparation and briefing dispositive and pre-trial motions.
Acted as national coordinating counsel for a multinational medical device manufacturer in claims related to its orthopedic products, including representing the manufacturer before the U.S. Judicial Panel on Multidistrict Litigation.
Member of team advising multinational pharmaceutical company on recall of popular consumer health product.
See more
February 3, 2022
Upcoming Rulings Key To Defining PREP Act Protections
January 11, 2017
Will The Learned Intermediary Doctrine Survive A New Paradigm?
July 15, 2022
Mark Sentenac, Susan Clare and Ryan Kearney advise AbbVie and Allergan in a product liability dispute
December 3, 2021
K&S elects 32 new partners and promotes 16 counsel across 16 cities
J.D., University of San Francisco School of Law, magna cum laude
B.S., University of California-Santa Barbara
California
Georgia
U.S. District Court for the Eastern District of California
U.S. District Court for the Northern District of California
U.S. District Court for the Southern District of California